Clinical Trial Update: Antiviral Prophylaxis in a Burn Population [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial investigating antiviral prophylaxis for herpes simplex in burn patients was withdrawn after Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex

Snippet

Sponsor: Southern Illinois University | Conditions: Herpes Simplex | Phase 2, Phase 3 | Status: WITHDRAWN